CS Pharmaceuticals Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
CS Pharmaceuticals General Information
Description
Developer of ophthalmology and rare disease pharmaceuticals designed to address unmet medical needs in specialty therapeutic areas. The company focuses on discovering, in-licensing, and developing drug candidates that target the underlying pathophysiology of meibomian gland dysfunction and associated dry eye disease, with activities spanning molecule selection, preclinical evaluation, clinical trial design, and regulatory preparation, enabling ophthalmology specialists and healthcare providers to access new treatment options that address unmet clinical needs in ocular surface care.
Contact Information
Website
www.cspharmaceuticals.comCorporate Office
- 167-169 Great Portland Street 5th Floor
- London W1W 5PF
- England, United Kingdom
Corporate Office
- 167-169 Great Portland Street 5th Floor
- London W1W 5PF
- England, United Kingdom
CS Pharmaceuticals Timeline
CS Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 3 | ||||
| 3. Later Stage VC | 31-Dec-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 25-Mar-2024 | $4.12M | $9.1M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC | 16-Nov-2021 | $4.96M | $4.96M | Completed | Clinical Trials - Phase 3 |
CS Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 853,809 | $0.000001 | $1.03 | $1.03 | 1x | $1.03 | 4.51% | |
| Ordinary | 4,257,151 | $0.000001 | $0.94 | $0.94 | 1x | $0.94 | 22.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CS Pharmaceuticals Patents
CS Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190151334-A1 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular suface | Active | 21-Nov-2017 | ||
| AU-2018372185-A1 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface | Active | 21-Nov-2017 | ||
| AU-2018372185-B2 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface | Active | 21-Nov-2017 | ||
| EP-3713544-A2 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface | Pending | 21-Nov-2017 | ||
| US-11759472-B2 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface | Active | 21-Nov-2017 | A61K31/573 |
CS Pharmaceuticals Signals
CS Pharmaceuticals Acquisitions (1)
CS Pharmaceuticals’s most recent deal was a Merger/Acquisition with AxeroVision. The deal was made on 28-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AxeroVision | 28-Jul-2023 | Merger/Acquisition | Drug Discovery |
CS Pharmaceuticals FAQs
-
When was CS Pharmaceuticals founded?
CS Pharmaceuticals was founded in 2020.
-
Where is CS Pharmaceuticals headquartered?
CS Pharmaceuticals is headquartered in London, United Kingdom.
-
What is the size of CS Pharmaceuticals?
CS Pharmaceuticals has 7 total employees.
-
What industry is CS Pharmaceuticals in?
CS Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is CS Pharmaceuticals a private or public company?
CS Pharmaceuticals is a Private company.
-
What is CS Pharmaceuticals’s current revenue?
The current revenue for CS Pharmaceuticals is .
-
How much funding has CS Pharmaceuticals raised over time?
CS Pharmaceuticals has raised $11.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process